Doxorubicin hydrochloride

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2670 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lymphoma	D008223	—	C85.9	142	428	187	17	42	732
Breast neoplasms	D001943	EFO_0003869	C50	96	343	132	13	84	612
Sarcoma	D012509	—	—	66	132	51	5	24	250
Large b-cell lymphoma diffuse	D016403	—	C83.3	54	152	54	3	11	241
Ovarian neoplasms	D010051	EFO_0003893	C56	73	106	67	2	16	232
B-cell lymphoma	D016393	—	—	62	135	47	4	8	217
Carcinoma	D002277	—	C80.0	47	106	44	5	33	212
Non-hodgkin lymphoma	D008228	—	C85.9	47	107	48	6	11	193
Leukemia	D007938	—	C95	42	86	51	8	7	175
Ovarian epithelial carcinoma	D000077216	—	—	55	74	48	2	12	169

Show 40 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	98	61	19	—	7	162
Fallopian tube neoplasms	D005185	—	—	31	32	23	—	1	74
Recurrence	D012008	—	—	24	33	14	—	7	68
Neuroblastoma	D009447	EFO_0000621	—	10	22	16	—	3	51
Osteosarcoma	D012516	—	—	11	21	11	—	8	44
Neoplasm metastasis	D009362	EFO_0009708	—	16	22	3	—	4	41
Endometrial neoplasms	D016889	EFO_0004230	—	5	20	18	—	—	41
Peritoneal neoplasms	D010534	—	—	13	19	7	—	6	40
Adenocarcinoma	D000230	—	—	9	19	9	—	2	33
Ewing sarcoma	D012512	EFO_0000173	—	5	17	7	—	4	31

Show 130 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Stomach neoplasms	D013274	EFO_0003897	C16	5	11	—	—	6	21
Male breast neoplasms	D018567	—	—	5	12	—	—	4	17
Invasive hydatidiform mole	D002820	—	D39.2	2	12	—	—	—	14
Non-small-cell lung carcinoma	D002289	—	—	4	9	—	—	—	11
Glioblastoma	D005909	EFO_0000515	—	4	8	—	—	—	11
Plasmablastic lymphoma	D000069293	—	C83.3	7	7	—	—	—	11
Large-cell lymphoma immunoblastic	D016400	—	—	7	7	—	—	—	11
Aids-related lymphoma	D016483	EFO_1001365	—	3	7	—	—	—	10
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	4	6	—	—	—	9
Urologic neoplasms	D014571	—	C64-C68	4	6	—	—	—	8

Show 138 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Myelodysplastic-myeloproliferative diseases	D054437	—	—	4	—	—	—	—	4
Appendiceal neoplasms	D001063	EFO_0003880	C18.1	2	—	—	—	2	4
Skin neoplasms	D012878	EFO_0004198	C44	1	—	—	—	1	2
Pleural effusion	D010996	—	J90	1	—	—	—	1	2
Pleural neoplasms	D010997	—	—	1	—	—	—	1	2
Castration-resistant prostatic neoplasms	D064129	—	—	1	—	—	—	—	1
Primary myelofibrosis	D055728	—	D47.4	1	—	—	—	—	1
Myelomonocytic leukemia chronic	D015477	—	C93.1	1	—	—	—	—	1
Anemia	D000740	EFO_0004272	D64.9	1	—	—	—	—	1
Leukemia myeloid chronic atypical bcr-abl negative	D054438	—	C92.2	1	—	—	—	—	1

Show 20 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Cardiovascular diseases	D002318	EFO_0000319	I98	—	—	—	—	4	4
Fatigue	D005221	—	R53.83	—	—	—	—	2	2
Pseudomyxoma peritonei	D011553	EFO_0007456	—	—	—	—	—	2	2
Thrombosis	D013927	—	—	—	—	—	—	2	2
Taste disorders	D013651	—	—	—	—	—	—	1	1
Dysgeusia	D004408	—	R43.2	—	—	—	—	1	1
Ageusia	D000370	EFO_1001758	—	—	—	—	—	1	1
Hepatitis a	D006506	EFO_0007305	B15	—	—	—	—	1	1
Ataxia	D001259	—	R27.0	—	—	—	—	1	1
Ataxia telangiectasia	D001260	Orphanet_100	G11.3	—	—	—	—	1	1